| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.099 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.02 |